Investors
Overview
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 42 countries as of March 31, 2024.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Recent News
Upcoming Events
- April 23, 2024 9:00 AM EDT
- May 17, 2024 9:00 AM EDT
Primary IR Contact
Medpace Holdings, Inc.
5375 Medpace Way
Cincinnati, OH 45227
Phone: +1.513.579.9911
investor@medpace.com